CHIH


MSCI China Health Care ETF

Fund Summary

The Global X MSCI China Health Care ETF (CHIH) seeks to invest in large- and mid-capitalization segments of the MSCI China Index that are classified in the Health Care Sector as per the Global Industry Classification System (GICS).

Fund Objective

The Global X MSCI China Health Care ETF (CHIH) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI China Health Care 10/50 Index.

Why CHIH?

Targeted Exposure

CHIH is a targeted play on the Health Care Sector in China – the world’s second largest economy by GDP.

ETF Efficiency

In a single trade, CHIH delivers access to dozens of health care companies within the MSCI China Index, providing investors an efficient vehicle to express a sector view on China.

All Share Exposure

The Index incorporates all eligible securities as per MSCI’s Global Investable Market Index Methodology, including China A, B and H shares, Red chips, P chips and foreign listings, among others.

Fund Details As of 1/23/20

Key Facts

Ticker CHIH
Inception Date 12/7/18
CUSIP 37954Y541
ISIN US37954Y5419
Bloomberg Index Ticker NU722071
Primary Exchange NYSE Arca

Stats & Fees

Net Assets $2,777,212
NAV $18.51
Shares Outstanding 150,002
Total Expense Ratio 0.65%

Distributions

30-Day SEC Yield 0.72%
Distribution Frequency Semi-Annually

Fund Prices As of 1/23/20

NAV Price
Net Asset Value $18.51 Closing Price $18.52
Daily Change -$0.55 -2.88% Daily Change -$0.30 -1.59%

Performance History

Cumulative %

Data as of month end (12/31/19)

Fund NAV Closing Price Index
1 Month 4.78% 4.41% 4.88%
3 Months 12.91% 13.20% 13.23%
6 Months 14.88% 14.81% 15.42%
Since Inception 18.55% 18.55% 19.52%

Avg Annualized %

Data as of month end (12/31/19)

Fund NAV Closing Price Index
1 Year 31.72% 30.94% 32.86%
Since Inception 17.33% 17.33% 18.21%

Avg Annualized %

Data as of quarter end (12/31/19)

Fund NAV Closing Price Index
1 Year 31.72% 30.94% 32.86%
Since Inception 17.33% 17.33% 18.21%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized Return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted.

Fund Characteristics As of 1/23/20

Return on Equity 12.40%
Average Market Cap $6,441.00 M
2018 2019
Price-to-earnings 30.43 27.07
Price-to-book value 3.50 3.20

Source: AltaVista Research, LLC

Fund Risk Stats As of 1/23/20

Versus Beta
S&P 500 0.99
MSCI EAFE 1.02
MSCI Emg. Mkts 0.81
Standard Deviation 24.50%

Source: AltaVista Research, LLC

Top 10 Holdings

As of 1/23/20
Net Assets % Name Market Price ($) Shares Held Market Value ($)
8.96 WUXI BIOLOGICS CAYMAN INC 13.14 18,940 248,801.71
8.83 SINO BIOPHARMACEUTICAL 1.49 164,800 245,110.94
7.73 CSPC PHARMACEUTI 2.43 88,200 214,702.63
6.18 ALIBABA HEALTH 1.34 128,500 171,612.19
5.36 SINOPHARM GROUP CO-H 3.54 42,100 148,957.52
3.74 JIANGSU HENGRU-A 12.68 8,200 103,982.36
3.40 SHANDONG WEIG-H 1.24 76,500 94,488.80
3.32 INNOVENT BIOLOGICS INC 3.99 23,100 92,134.30
3.25 PING AN HEALTHCA 9.21 9,800 90,279.00
2.93 GENSCRIPT BIOTECH CORP 2.24 36,300 81,358.41
Holdings are subject to change. Cash, where shown, includes other assets and liabilities, such as payables and receivables.

Investing involves risk, including the possible loss of principal. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles, or from economic or political instability in other nations. Emerging markets involve heightened risks related to the same factors as well as increased volatility and lower trading volume. Securities focusing on a single country and narrowly focused investments may be subject to higher volatility. CHIH is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Global X NAVs are calculated using prices as of 4:00 PM Eastern Time. The closing price is the Mid-Point between the Bid and Ask price as of the close of exchange. Closing price returns do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by MSCI, nor does MSCI make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with MSCI.